REFERENCES
- Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81–128.
- Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathophysio-logical processes. Mol Aspects Med 2003; 24: 281–291.
- Poli G, Schaur RJ. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000; 50: 315–321.
- Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 2000; 28: 1685–1696.
- Asselin C, Bouchard B, TardifJ C, Des Rosiers C. Circulating 4-hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats. Free Radic Biol Med 2006; 41: 97–105.
- Benderdour M, Charron G, Deblois D, Comte B, Des Rosiers C. Cardiac mitochondrial NADP'-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. J Biol Chem 2003; 278: 45154–45159.
- Benderdour M, Charron G, Comte B et al. Decreased cardiac mitochondrial NADP'-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development. Am J Physiol 2004; 287: H2122–H2131.
- Cosentino F, Patton S, d'Uscio LV et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101: 1530–1537.
- Cabassi A, Dumont EC, Girouard H et al. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 2001; 19: 1233–1244.
- Blasig IE, Grune T, Schonheit K et al. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol 1995; 269: H14–H22.
- Franks AM, Gardner SF. AGI-1067: a novel vascular protectant for prevention of restenosis. Ann Pharmacother 2006; 40: 66–73.
- Slama M, Ahn J, Varagic J, Susie D, Frohlich ED. Long-term left ventricular echocardiographic follow-up of SHRs and WKY rats: effects of hypertension and age. Am J Physiol 2004; 286: HI 81—H185.
- Nakamura R, Egashira K, Machida Y et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 2002; 106: 362–367.
- Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967–974.
- Nakamura K, Kusano KF, Matsubara H et al. Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail 2005; 11: 117–123.
- Sia YT, Lapointe N, Parker TG et al. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 2002; 105: 2549–2555.
- Ishikawa T, Esterbauer H, Sies H. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J Biol Chem 1986; 261: 1576–1581.
- Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ Res 1995; 76: 293–304.
- Aberle NS, Picklo Sr MJ, Amarnath V, Ren J. Inhibition of cardiac myocyte contraction by 4-hydroxy-trans-2-nonenal. Cardiovasc Toxicol 2004; 4: 21–28.
- Ahn J, Varagic J, Slama M, Susie D, Frohlich ED. Cardiac structural and functional responses to salt loading in SHRs. Am J Physiol 2004; 287: H767–H772.